SCHEMBL21667353

SCHEMBL21667353

O=c1cc(NCc2ccccc2)[nH]c(=O)n1CCOCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ CDC25B P30305 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PIK3CB P42338 2/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.39
▸ ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667212 0.86 MEN1 (0.60) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667187 0.82 SMN1; SMN2 (0.54) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667215 0.79 SMN1; SMN2 (0.53) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL22639826 0.77 SMN1; SMN2 (0.74) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667273 0.76 SMN1; SMN2 (0.44) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667214 0.75 SMN1; SMN2 (0.47) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667360 0.75 SMN1; SMN2 (0.47) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL21667206 0.75 SMN1; SMN2 (0.47) SMN1; SMN2TP53MEN1KMT2ACDC25B
SCHEMBL3474311 0.74 — —
SCHEMBL21667364 0.74 SMN1; SMN2 (0.46) SMN1; SMN2TP53MEN1KMT2ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback